Last reviewed · How we verify

NCT04174443: PRFCRF

The Efficacy and Safety of Pulsed Radiofrequency Combined With Continuous Radiofrequency for the Trigeminal Neuralgia

Completed NA Last updated 6 August 2024
What this trial tests

NA trial testing High-voltage pulsed radiofrequency in Trigeminal Neuralgia in 146 participants. Completed in 26 October 2022.

Timeline
2 December 2020
Primary endpoint
26 October 2022
26 October 2022

Quick facts

Lead sponsorBeijing Tiantan Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment146
Start date2 December 2020
Primary completion26 October 2022
Estimated completion26 October 2022
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Beijing Tiantan Hospital

Who can join

Adults 18 to 75, any sex, with Trigeminal Neuralgia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Trigeminal neuralgia is a very painful condition, and radiofrequency therapy is reserved for patients who are resistant or intolerant to pharmacological therapy. Continuous radiofrequency and pulsed radiofrequency both have advantages and disadvantages. Recently, studies have found that pulsed radiofrequency combined with low-temperature (\<65 °C) continuous radiofrequency increases the efficacy of the treatment, without leading to a significant increase in complications caused by nerve lesions. However, these reports have some limitations. The investigators plan to conduct a randomized, controlled study to compare the efficacy of applying high-voltage pulsed radiofrequency, with and without low-temperature continuous radiofrequency, to the gasserian ganglion for the treatment of trigeminal neuralgia. The primary outcome will be the effectiveness of the treatment after 12 months which is the percentage of participants with a modified Barrow Neurological Institute Pain Intensity Score between I-III.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. The Efficacy and Safety of the Application of Pulsed Radiofrequency, Combined With Low-Temperature Continuous Radiofrequency, to the Gasserian Ganglion for the Treatment of Primary Trigeminal Neuralgia: Study Protocol for a Prospective, Open-Label, Parall.
    Ren H, Zhao C, Wang X, Shen Y, et al · · 2021 · cited 9× · PMID 33400432
  2. The efficacy of combining pulsed radiofrequency with low-temperature continuous radiofrequency for the treatment of primary trigeminal neuralgia: a randomized controlled trial.
    Zhao C, Ren H, Shrestha N, Meng L, et al · · 2025 · PMID 40053922 · DOI 10.3171/2024.10.jns241274

Verify or expand the search:

Other trials of High-voltage pulsed radiofrequency

Trials testing the same drug.

Other recruiting trials for Trigeminal Neuralgia

Currently open trials in the same condition.

Other Beijing Tiantan Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04174443.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing